CABANA
2019
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
In 2,204 patients with symptomatic atrial fibrillation, catheter ablation did not significantly reduce death, disabling stroke, serious bleeding, or cardiac arrest compared with antiarrhythmic drug therapy.
Result
Efficacy: Composite of death, disabling stroke, serious bleeding, or cardiac arrestHR 0.86 (95% CI 0.65-1.15) · P = 0.30
Below 1 favours catheter ablation, above 1 favours antiarrhythmic drug therapy.
- Absolute difference
- 1.2 points
The absolute difference is derived from the event rates.
Also reported: Neutral by intention-to-treat. Per-protocol and as-treated analyses favoured ablation.
- Subtopic
- Ablation
- Design
- Open-label multicentre RCT
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2024 AFACC/AHA 2023 AF
- Source
- Packer DL, et al. JAMA. 2019;321(13):1261-1274.doi 10.1001/jama.2019.0693
Discussion & critique
Substantial crossover between arms diluted the intention-to-treat comparison. Although the primary endpoint was neutral, ablation improved quality of life and became reasonable first-line rhythm control for symptomatic AF.